Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study
Sign Up to like & getrecommendations! Published in 2022 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfac157
Abstract: ABSTRACT Background In FIGARO-DKD, finerenone reduced the risk of cardiovascular events in patients with type 2 diabetes (T2D) and stage 1–4 chronic kidney disease (CKD). In FIDELIO-DKD, finerenone improved kidney and cardiovascular outcomes in patients… read more here.
Keywords: figaro dkd; kidney; kidney outcomes; finerenone ... See more keywords